Clinical Trial Update: Docetaxel in Treating Patients With Stage IV Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating docetaxel in patients with stage IV prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Pain, Prostate Cancer | Phase 2 | Status: COMPLETED